Toshiki Kajihara
-
- Antibiotic Use and Resistance 8
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 12
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing 10
- Endocrinology top 10%
- Infectious Diseases top 10%
- Antimicrobial Resistance in Staphylococcus 7
- Clostridium difficile and Clostridium perfringens research 3
-
- Pneumonia and Respiratory Infections 5
- Respiratory viral infections research 2
-
- Nosocomial Infections in ICU 5
Toshiki Kajihara
32 papers receiving 447 citations
Peers
Comparison fields: 5 of 83
- Applied Microbiology and Biotechnology 102
- Molecular Medicine 127
- Clinical Biochemistry 89
- Endocrinology 48
- Infectious Diseases 139
Countries citing papers authored by Toshiki Kajihara
This map shows the geographic impact of Toshiki Kajihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiki Kajihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiki Kajihara more than expected).
Fields of papers citing papers by Toshiki Kajihara
This network shows the impact of papers produced by Toshiki Kajihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiki Kajihara. The network helps show where Toshiki Kajihara may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Toshiki Kajihara, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 7 | |
| 7 | 2023 | 12 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 20 | |
| 11 | 2022 | 17 | |
| 12 | 2022 | 10 | |
| 13 | 2021 | 38 | |
| 14 | 2020 | 17 | |
| 15 | 2019 | 33 | |
| 16 | 2019 | 58 | |
| 17 | 2018 | 16 | |
| 18 | 2017 | 15 | |
| 19 | 2017 | 7 | |
| 20 | 2015 | 19 |
About Toshiki Kajihara
Toshiki Kajihara is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Clinical Biochemistry, having authored 34 papers that have together received 454 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (12 papers), Bacterial Identification and Susceptibility Testing (10 papers), Antibiotic Use and Resistance (8 papers), Antimicrobial Resistance in Staphylococcus (7 papers), Pneumonia and Respiratory Infections (5 papers), Nosocomial Infections in ICU (5 papers), Clostridium difficile and Clostridium perfringens research (3 papers) and Respiratory viral infections research (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (102 citations), Molecular Medicine (127 citations) and Clinical Biochemistry (89 citations). Toshiki Kajihara has collaborated with scholars based in Japan, Australia and United States. Frequent co-authors include Motoyuki Sugai, Koji Yahara, Aki Hirabayashi, Keigo Shibayama, Shigeru Kohno, Shigeki Nakamura, Katsunori Yanagihara, Taiga Miyazaki, Naoki Iwanaga and Hiroki Ohge. Their work appears in journals such as Nature Communications, PLoS ONE and Applied and Environmental Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.